| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | NEUTRAL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.04▲ | 1.04▲ | 1.04▲ | 1.03▲ | 1.09▼ |
| MA10 | 1.03▲ | 1.03▲ | 1.04▲ | 1.03▲ | 1.24▼ |
| MA20 | 1.03▲ | 1.05▲ | 1.06▼ | 1.09▼ | 1.36▼ |
| MA50 | 1.10▼ | 1.13▼ | 1.14▼ | 1.26▼ | 1.84▼ |
| MA100 | 1.17▼ | 1.20▼ | 1.22▼ | 1.39▼ | 2.00▼ |
| MA200 | 1.23▼ | 1.31▼ | 1.33▼ | 1.77▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.008▲ | 0.006▲ | 0.005▲ | 0.006▲ | -0.018▼ |
| RSI | 48.926▼ | 44.705▼ | 43.706▼ | 39.988▼ | 33.865▼ |
| STOCH | 94.444▲ | 53.889 | 42.778 | 50.280 | 9.356▼ |
| WILL %R | 0.000▲ | -33.333 | -33.333 | -53.271 | -85.000▼ |
| CCI | 171.254▲ | 61.765 | 46.285 | 5.873 | -124.056▼ |
|
Wednesday, October 14, 2026 01:18 PM
ImmunityBio, Inc. (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced that the U.S. Food and Drug Administration (FDA) has expanded the approved indication for ANKTIVA® ...
|
|
Thursday, September 03, 2026 07:54 AM
ImmunityBio looks attractive due to ANKTIVA's FDA approval for BCG-unresponsive NMIBC and pipeline expansion potential. See why I rate IBRX stock a Buy.
|
|
Sunday, June 07, 2026 05:00 PM
Agilent Technologies Inc. (NYSE: A) announced a collaboration with OpenAI and Boston Consulting Group (BCG) to accelerate the deployment of artificial intelligence (AI) across the company’s products, ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 16/10/26 | 1.055 | 1.055 | 1.055 | 1.055 | 4 |
| 15/10/26 | 1.015 | 1.035 | 1.015 | 1.03 | 4,503 |
| 14/10/26 | 1.00 | 1.02 | 0.9977 | 1.00 | 26,811 |
| 13/10/26 | 1.01 | 1.04 | 0.9999 | 1.02 | 10,157 |
| 12/10/26 | 1.03 | 1.035 | 1.01 | 1.03 | 18,909 |
| 09/10/26 | 1.07 | 1.07 | 1.0321 | 1.05 | 3,020 |
| 08/10/26 | 0.99 | 1.06 | 0.95 | 1.045 | 30,596 |
| 07/10/26 | 1.03 | 1.0352 | 0.9701 | 0.9907 | 22,921 |
| 06/10/26 | 1.03 | 1.07 | 1.025 | 1.05 | 6,787 |
| 05/10/26 | 1.04 | 1.0899 | 1.0304 | 1.05 | 17,273 |
|
|
||||
|
|
||||
|
|